腹腔鏡手術 出血少、恢復快Laparoscopic surgery less bleeding, rapid recovery

腹腔鏡手術 出血少、恢復快 【劉惠敏】由於手術進步、標靶藥物等新發展，目前大腸直腸癌治療方式頗有進展，也有不錯的治癒機會。 中國醫藥大學附設醫院大腸直腸外科主任陳自諒說明，目前大腸直腸癌的治療多半以手術為主，近來運用腹腔鏡切除手術，不僅出血少、恢復快，也大大縮短住院日數，許多病人手術三天後就可以出院。 如在電視看棒賽 比現場清楚 他形容，腹腔鏡手術就像在電視轉播看洋基隊的比賽，比在現場還要清楚可見投手王建民的一舉一動，如今運用腹腔鏡手術，可以更好的切除病灶。 美國食品藥物管理局（FDA）也證實，運用腹腔鏡切除大腸直腸癌手術，與傳統手術復發率、存活率相當。 轉移性腸癌 須藥物治療 肝臟、肺臟是大腸直腸癌最容易發生遠端轉移部位，轉移性腸癌則必須使用藥物治療，陳自諒說，目前藥物治療效果還不錯，能大大提升存活率，傳統的化療藥物如5-FU有口服、注射兩種選擇，另外還有標靶藥物如血管新生抑製劑及表皮細胞生長因子抑制劑。 標靶治療突破以往腸癌患者因轉移、無法開刀、存活的困境，標靶藥物可以鎖定癌細胞中的特殊構造，消滅癌細胞而不傷害正常細胞，有別於傳統化療摧毀癌細胞時，同時傷害到正常組織。 以血管新生抑制劑來說，其能抑制癌細胞周遭血管新生，使癌細胞失去養分來源，國際大型研究第三期臨床試驗指出，化療合併血管新生抑製劑，比單純化療療效、存活期增加。 陳自諒說，手術或使用不同藥物治療的效果因人而異，標靶藥物的成效頗佳，但藥費極昂貴，美國食品藥物管理局腫瘤中心已通過血管新生抑制劑（Avastin）為標靶治療第一線用藥。 2008-10-06 Laparoscopic surgery less bleeding, rapid recovery LIU Hui-min】 【due to the progress of surgery, such as new drug target development, the current treatment for colorectal cancer rather, there is also a good opportunity to heal. China Medical University Hospital, director of colorectal surgery since Chen understanding that the current treatment of colorectal cancer surgery mostly to the recent use of laparoscopic surgery is not only less bleeding, rapid recovery, but also significantly reduce the number of days of hospitalization, many patients surgery three days Can be discharged from hospital later. If the baseball game on TV than live to see clearly He described laparoscopic surgery as in the TV to see the Yankees game, but also at the scene, it is clear that every move of the pitcher Chien-Ming Wang, now the use of laparoscopic surgery, the better the removal of lesions. U.S. Food and Drug Administration (FDA) has confirmed that the use of laparoscopic resection of colorectal cancer surgery, the recurrence rate with traditional surgery, the survival rate of very. The treatment of metastatic colorectal cancer drug to be Liver, lung colorectal cancer is the most vulnerable parts of distant metastases, metastatic colorectal cancer treatment drugs must be used, since the Chen-liang said that drug treatment was not bad, can greatly improve survival rates, the traditional chemotherapy drug 5-FU as a Oral, injection two options, as well as drug targets, such as angiogenesis inhibitors and epidermal growth factor inhibitors. Target breakthrough in the treatment of patients with colorectal cancer in the past as a result of the transfer, not surgery, the survival of the plight of drug target cancer cells can be locked in special construction, the eradication of cancer cells without harming normal cells, unlike traditional chemotherapy to destroy cancer cells, at the same time Damage to normal tissue. To angiogenesis inhibitors, the cancer cells can inhibit angiogenesis around, so that cancer cells lose their source of nutrients, international Phase III study of large-scale clinical trials that the angiogenesis inhibitor combined chemotherapy than chemotherapy alone, the increase in survival. Chen said that since the understanding, the surgery or the use of different drug treatment varies from person to person, the effectiveness of the drug target good, but very expensive drugs, the U.S. Food and Drug Administration Center for tumor angiogenesis inhibitors have been adopted by the (Avastin) to target treatment First-line drugs. 2008-10-06 View more information, see the World Journal reported that e-ePaper

瀏覽更多新聞，請看世界日報電子報 ePaper。